When did Lexaria Bioscience report Q1 2025 earnings?

Lexaria Bioscience (LEXX) reported Q1 2025 earnings on April 14, 2025 before market open.

What were Lexaria Bioscience's Q1 2025 revenue and EPS?

Lexaria Bioscience reported revenue of $174.0K and diluted EPS of $-0.15 for Q1 2025.

Revenue beat the consensus estimate of $91.3K by $82.7K. EPS beat the consensus estimate of $-0.16 by $0.01.

You can read the 10-Q periodic report (0001640334-25-000629) directly on SEC EDGAR. The filing index links above go to sec.gov.

Reported April 14, 2025 · Before market open

Revenue estimate$91.3K

EPS estimate-$0.16

Jul 13, 2026 (In 3 weeks)

Revenue estimate$50.0K

EPS estimate-$0.06

Q1 2025$174.0KBeat by $82.7K

Q1 2025-$0.15Beat by $0.01

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

When did Lexaria Bioscience report Q1 2025 earnings?: Lexaria Bioscience (LEXX) reported Q1 2025 earnings on April 14, 2025 before market open.
What were Lexaria Bioscience's Q1 2025 revenue and EPS?: Lexaria Bioscience reported revenue of $174.0K and diluted EPS of $-0.15 for Q1 2025.
Did Lexaria Bioscience beat estimates in Q1 2025?: Revenue beat the consensus estimate of $91.3K by $82.7K. EPS beat the consensus estimate of $-0.16 by $0.01.
Where can I find Lexaria Bioscience's Q1 2025 SEC filings?: You can read the 10-Q periodic report (0001640334-25-000629) directly on SEC EDGAR. The filing index links above go to sec.gov.